These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 6202874)

  • 1. Complete nucleotide sequences of all three poliovirus serotype genomes. Implication for genetic relationship, gene function and antigenic determinants.
    Toyoda H; Kohara M; Kataoka Y; Suganuma T; Omata T; Imura N; Nomoto A
    J Mol Biol; 1984 Apr; 174(4):561-85. PubMed ID: 6202874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome.
    Nomoto A; Omata T; Toyoda H; Kuge S; Horie H; Kataoka Y; Genba Y; Nakano Y; Imura N
    Proc Natl Acad Sci U S A; 1982 Oct; 79(19):5793-7. PubMed ID: 6310545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping of attenuating sequences of an avirulent poliovirus type 2 strain.
    Moss EG; O'Neill RE; Racaniello VR
    J Virol; 1989 May; 63(5):1884-90. PubMed ID: 2539491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approaches to the development of new poliovirus vaccines based on molecular genetics.
    Nomoto A; Toyoda H; Kataoka Y; Kohara M; Suganuma T; Omata T; Imura N
    Rev Infect Dis; 1984; 6 Suppl 2():S494-8. PubMed ID: 6330845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nucleotide sequence of poliovirus type 3 leon 12 a1b: comparison with poliovirus type 1.
    Stanway G; Cann AJ; Hauptmann R; Hughes P; Clarke LD; Mountford RC; Minor PD; Schild GC; Almond JW
    Nucleic Acids Res; 1983 Aug; 11(16):5629-43. PubMed ID: 6310508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleotide sequence from neurovirulent and attenuated strains of type 3 poliovirus.
    Almond JW; Cann AJ; Minor PD; Reeve P; Schild GC; Hauptmann R; Stanway G
    Rev Infect Dis; 1984; 6 Suppl 2():S487-93. PubMed ID: 6330844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nucleotide sequence of a type 3 poliovirus isolated during a recent outbreak of poliomyelitis in Finland.
    Hughes PJ; Evans DM; Minor PD; Schild GC; Almond JW; Stanway G
    J Gen Virol; 1986 Oct; 67 ( Pt 10)():2093-102. PubMed ID: 3020156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleotide sequences of the VP1 capsid proteins of wild poliovirus types 1 and 3 from epidemic areas of Brazil.
    Da-Silva EE; Schatzmayr HG; Kew OM
    Braz J Med Biol Res; 1990; 23(1):1-5. PubMed ID: 2167137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Location and primary structure of a major antigenic site for poliovirus neutralization.
    Minor PD; Schild GC; Bootman J; Evans DM; Ferguson M; Reeve P; Spitz M; Stanway G; Cann AJ; Hauptmann R; Clarke LD; Mountford RC; Almond JW
    Nature; 1983 Feb; 301(5902):674-9. PubMed ID: 6186919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of poliovirus complementary DNA coding for viral antigenic determinants in Escherichia coli.
    Kuge S; Chisaka O; Kohara M; Imura N; Matsubara K; Nomoto A
    J Biochem; 1984 Aug; 96(2):305-12. PubMed ID: 6209264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variation of the poliovirus genome with two VPg coding units.
    Cao X; Wimmer E
    EMBO J; 1996 Jan; 15(1):23-33. PubMed ID: 8598203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the complete nucleotide sequences of the genomes of the neurovirulent poliovirus P3/Leon/37 and its attenuated Sabin vaccine derivative P3/Leon 12a1b.
    Stanway G; Hughes PJ; Mountford RC; Reeve P; Minor PD; Schild GC; Almond JW
    Proc Natl Acad Sci U S A; 1984 Mar; 81(5):1539-43. PubMed ID: 6324200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outbreak of poliomyelitis in Finland in 1984-85 - Re-analysis of viral sequences using the current standard approach.
    Simonen ML; Roivainen M; Iber J; Burns C; Hovi T
    Virus Res; 2010 Jan; 147(1):91-7. PubMed ID: 19883702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse neurovirulence determinants of poliovirus type 1 strain LS-a map to the coding regions of capsid protein VP1 and proteinase 2Apro.
    Lu HH; Yang CF; Murdin AD; Klein MH; Harber JJ; Kew OM; Wimmer E
    J Virol; 1994 Nov; 68(11):7507-15. PubMed ID: 7933134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of two determinants that attenuate vaccine-related type 2 poliovirus.
    Ren RB; Moss EG; Racaniello VR
    J Virol; 1991 Mar; 65(3):1377-82. PubMed ID: 1847458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine.
    Westrop GD; Wareham KA; Evans DM; Dunn G; Minor PD; Magrath DI; Taffs F; Marsden S; Skinner MA; Schild GC
    J Virol; 1989 Mar; 63(3):1338-44. PubMed ID: 2536836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the initiation site of poliovirus polyprotein synthesis.
    Dorner AJ; Dorner LF; Larsen GR; Wimmer E; Anderson CW
    J Virol; 1982 Jun; 42(3):1017-28. PubMed ID: 6284987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translation deficiency of the Sabin type 3 poliovirus genome: association with an attenuating mutation C472----U.
    Svitkin YV; Cammack N; Minor PD; Almond JW
    Virology; 1990 Mar; 175(1):103-9. PubMed ID: 2155504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical role of an eight-amino acid sequence of VP1 in neutralization of poliovirus type 3.
    Evans DM; Minor PD; Schild GS; Almond JW
    Nature; 1983 Aug 4-10; 304(5925):459-62. PubMed ID: 6192344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary structure of poliovirus defective-interfering particle genomes and possible generation mechanisms of the particles.
    Kuge S; Saito I; Nomoto A
    J Mol Biol; 1986 Dec; 192(3):473-87. PubMed ID: 3031313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.